Dextera Surgical Debt to Equity Ratio 2010-2017 | DXTRQ
Current and historical debt to equity ratio values for Dextera Surgical (DXTRQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Dextera Surgical debt/equity for the three months ending September 30, 2017 was 0.00.
| Dextera Surgical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2017-09-30 | $0.02B | $-0.01B | -1.79 |
| 2017-06-30 | $0.02B | $-0.01B | -2.05 |
| 2017-03-31 | $0.01B | $0.00B | -2.50 |
| 2016-12-31 | $0.01B | $0.00B | 20.22 |
| 2016-09-30 | $0.01B | $0.00B | 2.33 |
| 2016-06-30 | $0.01B | $0.01B | 1.16 |
| 2016-03-31 | $0.01B | $0.01B | 0.78 |
| 2015-12-31 | $0.01B | $0.01B | 0.59 |
| 2015-09-30 | $0.01B | $0.02B | 0.46 |
| 2015-06-30 | $0.01B | $0.02B | 0.33 |
| 2015-03-31 | $0.01B | $0.03B | 0.30 |
| 2014-12-31 | $0.01B | $0.03B | 0.26 |
| 2014-09-30 | $0.01B | $0.04B | 0.21 |
| 2014-06-30 | $0.01B | $0.04B | 0.18 |
| 2014-03-31 | $0.01B | $0.00B | -146.19 |
| 2013-12-31 | $0.01B | $0.00B | 1.81 |
| 2013-09-30 | $0.01B | $0.01B | 0.93 |
| 2013-06-30 | $0.01B | $0.01B | 0.62 |
| 2013-03-31 | $0.01B | $0.02B | 0.51 |
| 2012-12-31 | $0.01B | $0.00B | 1.61 |
| 2012-09-30 | $0.01B | $0.01B | 0.83 |
| 2012-06-30 | $0.01B | $0.01B | 0.60 |
| 2012-03-31 | $0.01B | $0.01B | 0.51 |
| 2011-12-31 | $0.01B | $0.00B | 1.79 |
| 2011-09-30 | $0.01B | $0.01B | 0.72 |
| 2011-06-30 | $0.00B | $0.01B | 0.29 |
| 2011-03-31 | $0.00B | $0.01B | 0.37 |
| 2010-12-31 | $0.00B | $0.01B | 0.24 |
| 2010-09-30 | $0.00B | $0.02B | 0.18 |
| 2010-06-30 | $0.00B | $0.01B | 0.51 |
| 2010-03-31 | $0.00B | $0.01B | 0.43 |
| 2009-12-31 | $0.00B | $0.01B | 0.30 |
| 2009-09-30 | $0.00B | $0.01B | 0.27 |
| 2009-06-30 | $0.00B | $0.01B | 0.65 |
| 2009-03-31 | $0.01B | $0.01B | 0.54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Dextera Surgical Inc. designs and manufactures proprietary stapling devices for surgical procedures. The company's product consists of MicroCutter 5/80 use for transection and resection in urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the intestine and the transection of the appendix. Dextera Surgical Inc., formerly known as Cardica Inc., is headquartered in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.170B | 21.80 |
| Intuitive Surgical (ISRG) | United States | $179.421B | 74.37 |
| Edwards Lifesciences (EW) | United States | $47.608B | 31.58 |
| IDEXX Laboratories (IDXX) | United States | $46.009B | 52.87 |
| Alcon (ALC) | Switzerland | $43.988B | 29.73 |
| DexCom (DXCM) | United States | $34.921B | 52.39 |
| IQVIA Holdings (IQV) | United States | $32.562B | 18.40 |
| Mettler-Toledo (MTD) | United States | $26.309B | 31.29 |
| STERIS (STE) | Ireland | $22.554B | 24.84 |
| Waters (WAT) | United States | $17.797B | 25.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.385B | 0.00 |
| Hologic (HOLX) | United States | $14.480B | 15.66 |
| Sysmex ADR (SSMXY) | Japan | $10.386B | 29.46 |
| Penumbra (PEN) | United States | $9.845B | 72.42 |
| Masimo (MASI) | United States | $8.459B | 31.20 |
| Globus Medical (GMED) | United States | $7.236B | 17.24 |
| Glaukos (GKOS) | United States | $5.374B | 0.00 |
| Teleflex (TFX) | United States | $5.034B | 8.31 |
| Integer Holdings (ITGR) | United States | $3.810B | 19.01 |
| TransMedics (TMDX) | United States | $3.643B | 55.80 |
| PROCEPT BioRobotics (PRCT) | United States | $2.841B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.400B | 14.29 |
| Nihon Kohden (NHNKY) | Japan | $1.956B | 22.43 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Veracyte (VCYT) | United States | $1.877B | 26.34 |
| Alphatec Holdings (ATEC) | United States | $1.568B | 0.00 |
| Artivion (AORT) | United States | $1.348B | 126.28 |
| Tandem Diabetes Care (TNDM) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.961B | 5.11 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.742B | 37.66 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| AxoGen (AXGN) | United States | $0.601B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.540B | 8.40 |
| OrthoPediatrics (KIDS) | United States | $0.527B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.495B | 10.66 |
| Pacific Biosciences Of California (PACB) | United States | $0.447B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.445B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.434B | 10.08 |
| Delcath Systems (DCTH) | United States | $0.381B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.364B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.348B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| NeuroPace (NPCE) | United States | $0.287B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.30 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.200B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Accuray (ARAY) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.120B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 52.90 |
| EnVVeno Medical (NVNO) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 20.33 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.74 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |